Resp conditions Flashcards
COPD
What is it?
What are its Risk factors?
What is its biggest cause?
A lung disease state characterised by chronic respiratory symptoms and airflow limitation. It encompasses emphysema and chronic bronchitis.
RF - SMOKING, elderly, air pollution, genetic factors (A1AT deficiency)
PATHOLOGY
Smoking is the biggest cause of COPD.
Chronic bronchitis and emphysema aren’t actually separate conditions AS MOST PATIENTS PRESENT WITH A MIX OF BOTH
Chronic bronchitis
RF
PATHOLOGY
SYMPTOMS
INVESTIGATIONS
TREATMENTS
A type of COPD
RF- Smoking, air pollution
Chronic bronchitis
- Characterised as a productive cough for at least 3 months for at least 2 consecutive years
- Exposure to irritants and chemicals –> hypertrophy and hyperplasia of mucinous glands and goblet cells –> increased mucous secretion –> narrows lumen and can cause airway obstruction (increasing risk of infection and airway trapping)
- Chronic inflammation of the bronchi and bronchioles can lead to progressive fibrosis (and also narrows the lumen)
With airway obstruction –> CO2 is trapped in the lungs and in the blood which can cause cyanosis –> BLUE BLOATER
SYMPTOMS
- Productive cough (mucus) - White sputum
- Dyspnoea
- Cyanosis
- Wheezing (due to airway obstruction)
(Overweight due to oedema)
INVESTIGATIONS
Spirometry - A FEV1/FVC ratio less than 0.7 would indicate airflow obstruction
Diffusing capacity of the lung for carbon monoxide (DLCO) - Low in COPD -< 60% predicted (normal in asthma)
Genetic test for A1AT deficiency
ABG - TYPE 2 RESPIRATORY FAILURE (Hypercapnia, hypoxia and respiratory acidosis)
Chest X-ray –> flattened diaphragm and hyperinflation of the lung - Barrel Chest
TREATMENT
Actual 1st line treatment -
Smoking cessation and preventive vaccines for influenza and pneumococcal (as airway obstruction increases risk of infection)
1st line - Salbutamol (SAB2A)
2nd line - Salbutamol + Salmeterol (LAB2A) + Tiotropium bromide (LAM3A)
(If still doesn’t work add inhaled corticosteroids)
Emphysema
-lifestyle treatment and pharmacological treatment
-2 types of emphysema
RF
PATHOLOGY
SYMPTOMS
INVESTIGATIONS
TREATMENTS
A destruction of the elastin layer in the alveolar sacs and respiratory bronchioles –> as elastin keeps these walls open during expiration (bernouli principle) –> decreased elastin results in alveoloar collapse and air being trapped distal to the blockage and there is difficulty exhaling. (Elastic recoil of lung tissue for exhalation is lost)
Different types of emphysema:
Centriacinar emphysema –> Respiratory bronchioles (and proximal alveoli) - Main cause smoking
Panacinar emphysema –> The entire acinar is affected - associated with Main cause A1AT deficiency
Known as PINK PUFFER
- Minimal cough
- Pursed lip breathing
- Barrel chest
- Hyper-resonance on percussion
(Cachexic - thinner because of muscle loss)
Can lead to bullae rupture (enlarge air sacs/spaces due to airflow obstruction) - possible pneumothorax complication
INVESTIGATIONS
Spirometry - A FEV1/FVC ratio less than 0.7 would indicate airflow obstruction
Diffusing capacity of the lung for carbon monoxide (DLCO) - Low in COPD -< 60% predicted (normal in asthma)
Genetic test for A1AT deficiency
ABG - TYPE 2 RESPIRATORY FAILURE (Hypercapnia, hypoxia and respiratory acidosis)
Chest X-ray –> flattened diaphragm and hyperinflation of the lung - Barrel Chest
TREATMENT
Actual 1st line treatment–> Smoking cessation and preventive vaccines for influenza and pneumococcal (as airway obstruction increases risk of infection)
1st line drug treatment- Salbutamol (SABA)
2nd line - Salbutamol + Salmeterol (LABA) + Tiotropium (LAMA)
(If still doesn’t work add inhaled corticosteroids)
What is a complication of COPD?
Cor pulmonale which is pulmonary hypertension resulting in abnormal enlargement of the right side of the heart
Asthma
- Key symptom
- What would you see on sputum culture
RF
PATHOLOGY
SYMPTOMS
INVESTIGATIONS
TREATMENTS
A chronic inflammatory airway disease that leads to airway obstruction (that is reversible). Characterised by reversible, intermittent airway obstruction and hyper-reactivity.
RF- Family history, allergens/irritants, atopic disease history (asthma is an atopic condition and patients with one atopic condition is likely to have others e.g. eczema, hay fever, food allergies), smoking
PATHOLOGY
Overexpressed T helper 2 cells in airways are exposed to the trigger (hypersensitive airway) –> leads to IgE production and EOSINOPHIL recruitment –> IgE triggers mast cell degranulation releasing prostaglandins and histamines. Eosinophils release Major basic protein - causes release of histamine from mast cells. –> results in bronchial constriction and mucus hypersecretion
Atopic/allergic asthma (70%) - IgE mediated T1 hypersensitivity that occurs due to an environmental trigger e.g. pollen, smoke, dust –> often presents earlier (children)
Non Atopic/allergic asthma (30%) - Non IgE mediated –> mostly associated with smoking and presents later (adults)
SYMPTOMS
- Expiratory wheezing
- DIURNAL VARIATION (worse at night/early morning) and EPISODIC
- Dry cough
- Chest tightness
- Dyspnoea
INVESTIGATIONS
1st line - Spirometry
An FEV1:FVC ratio <70% indicates obstructive pathology (asthma/COPD)
Bronchodilator reversibility - Improvement in FEV1 post bronchodilator administration (irreversible in COPD) >12% improvement in FEV1
Fractional exhaled nitric oxide - Increased (biomarker for asthma - eosinophilic inflammation?)
Expiratory peak flow >20% (checking diurnal variation)
Sputum microscopy
- Charcot leyden crystals - eosniophil breakdown products
- Curshmann spirals- plugs formed from bronchial epithelial shedding
TREATMENT
Algorithm
1) SAB2A (salbutamol) PRN
2) SAB2A + Inhaled corticosteroids (budesonide)
–> Check compliance and inhaler technique if still does not work. If still not ok –> Step 3
3) SAB2A + inhaled corticosteroids + Leukotriene receptor antagonist (montelukast)
4) SAB2A + inhaled corticosteroids + Leukotriene receptor antagonist + LAB2A (salmeterol)
5) Everything + increase dose of inhaled corticosteroid
Environmental triggers that can exacerbate symptoms of asthma
Infection, cold weather, exercise, Drugs - BB, NSAIDS (aspirin), animals
Grading for acute asthma
Peak expiratory flow of 50-75% (moderate exacerbation)
PEF of 33-50% (severe exacerbation) (Resp rate >30)
PEF <33%, SpO2 <92% (life threatening exacerbation) - cyanosis
- Wheeze disappears when the airways are so tight that there is no air entry (Silent Chest - life threatening)
CHEST
C - Cyanosis
H - Hypotension 90/60
E - Exhaution
S - Silent chest
T - Tachycardia
How would you manage exacerbations in asthma
OSHITME
Oxygen
Nebulised salbutamol
Hydrocortisone (or prednisolone)
Nebulised ipratropium bromide
Theophylline
Magnesium sulphate
E- Escalate care (intubate and ventilate)
What is the atopic triad?
Allergic rhinitis, eczema and asthma –>some people have all synonymously
Side effect of salbutamol
Serum potassium should be monitored with salbutamol treatment as it causes potassium to be absorbed from the blood in to the cells - hypokalemia.
It can also cause tachycardia and lactic acidosis.
What is Samter’s triad?
Also known as aspirin exacerbated respiratory disease
Triad of
- Asthma
- Sinus disease with recurrent nasal polyps
- Sensitivity to aspirin (and NSAIDS) that inhibits Cox-1and Cox-2
If people affected take NSAIDS –> It would lead to increased leukotriene production –> increasing bronchoconstriction
Tuberculosis
RF
PATHOLOGY
SYMPTOMS
INVESTIGATIONS
TREATMENTS
An infectious disease caused by Mycobacterium tuberculosis (Gram positive bacillus)
RF - Exposure to infection, birth in an endemic country, HIV, immunocompromised, (Africa and south asia), smoking
PATHOLOGY
TYPE 4 HYPERSENSITIVITY
- Spreads through the air (airborne/inhalation of aerosolised particles containing the bacterium)
- It has a thick waxy capsule which makes it resistant to phagolysosomal killing - so able to remain dormant in lung.
Upon inhalation of M.tuberculosis –> the bacteria is engulfed by alveolar macrophages but it survives and multiplies within the macrophages –> proliferating bacilli kill the macrophages are are released –> T cells and Giant cells (macrophages) form a caseous granuloma (CALLED GHON FOCUS - usually in upper parts of lung) with M tuberculosis which serves to prevent further growth and spread (individuals are considered non infectious and have latent TB).
However Ghon focus can spread to nearby lymph node - known as Ghon complex –> which allows it to spread systemically (Miliary TB - disseminated and severe disease that develops as a result of immune system not being able to control the infection)
(Mostly becomes dormant before progressing to active TB - It commonly involves the lungs but can affect other organ systems e.g. lymph nodes, CNS, liver, bones, GI tract, GU tract)
SYMPTOMS
Presents with chronic gradually worsening symptoms.
– Night sweats
- Weight loss
- Productive cough
- Possible chest pain
- Malaise, lethargy
- Erythema nodosum - tender, red nodules on shins caused by inflammation of subcutaneous fat
INVESTIGATIONS
1st line - Chest X-ray
Shows lung cavitations
Ghon focus/complex
Appearance of millet seeds distributed across lung firlds - indicated disseminated milliary tuberculosis
GS
Sputum culture (3 separate samples collected) - They are acid fast bacilli that stains bright red on a Ziehl-Neelson stain
Lung biopsy - Caseous granulomas
Two tests to look for an immune response to tuberculosis (positive means has an immune response)
Mantoux skin test - (people with latent TB have a positive tuberculin skin test with an induration >5mm after 72 hours)
Interferon Gamma release assays - If WBC have become sensitised to the bacteria antigen in a previous infection/contact with M.tuberculosis, there will release interferon gamma on further contact.
TB TO SPINE - POTT disease
TREATMENT
RI6PE2 (Ripe) - all to be taken at same time
Rifampicin - 6 months
Isoniazid - 6 months
Pyrazinamide - 2 months
Ethambutol - 2 months
Side effect of tuberculosis treatment and what should be co prescribed?
RIPE
Rifampicin, isoniazid, pyrazinamide, ethambutol
Rifampicin - Red bloody urine
Isoniazid can cause peripheral neuropathy –> Pyridoxine/vitamin B6 is given to counter this.
Pyrzinamide- hePatitis, arthralgia, rash
Ethambutol - Eyes - Optic neurities (visual problems)
Pneumonia
RF
PATHOLOGY
SYMPTOMS
INVESTIGATIONS
TREATMENTS
An infection of the lung tissue causing inflammation in the alveolar space and Fluid exudation into alveoli
RF - very young/old, residence in healthcare setting, IVDU, immunocompromised, pre existing respiratory disease
PATHOLOGY
Types:
1) Community acquired pneumonia
- Most commonly due to Streptococcus pneumoniae
- H.influenzae
- S.aureus
- Legionella - Europe (france, italy, spain) –> Water cooler/air conditioner
- Mycoplasma pneumoniae –> Causes atypical pneumonia
(Viral cause include influenza)
2) Hospital acquired pneumoniae (>48 hours of hospital admission)
- Gram negative aerobic bacteria: Pseudomonas aeruginosa, Klebsiella (associated with alcoholism)
- MRSA
3) Aspiration pneumonia - infection develops due to aspiration of food or fluids –> possible in patients with impaired swallowing - following a stroke. (Associated with anaerobic bacteria)
(ventilatory associated pneumonia)
Typical pneumonia - exudate forms inside alveoli lumen - sputum
Atypical pneumonia - exudate forms in interstitium
Fungal cause - -Pneumocystic Jirovecci - in immunocompromised patients
SYMPTOMS
Dyspnoea
Pleuritic chest pain - worse with breathing
Productive cough - (Brown/rusty sputum - s.pneumonia)
INCREASED TACTILE FREMITUS - voice is louder on certain parts of the chest.
Systemic - Fatigue, fever - due to infection
Dullness to percussion - due to lung tissue filled with sputum
Coarse inspiratory crackles (lungs)/crepitation - caused by air passing through sputum in the airways
(In atypical pneumonia - Dry cough with a low grade fever)
INVESTIGATION
1st line - Chest X-ray –> shows consolidation (accumulation of fluid filled (exudate) alveoli and adjoining ducts)
Sputum culture + stain with Ziehl Neelson - Identify the causative organism
ABG - Type 1 respiratory failure
CURB 65 - Assessses severity of penumonia
TREATMENT
Community acquired pneumonia (mild- CURB is 0-1)
1st line - Oral Amoxicillin
If penicillin allergy – Clarithromycin
CURB=2
Oral Amoxicillin + clarithromycin
Community acquired pneumonia (high severity - CURB 3-5)
IV Co amoxiclav + Clarithromycin
For legionnaires disease - clarithromycin (A NOTIFIABLE DISEASE)
3 causes of atypical pneumonia
Legionella pneumophila - usually a patient that went on a cheap holiday (e.g. inhaling infected water from an infected water system like air conditioning units)
Mycoplasma pneumoniae - mild pneumoniae with a rash (Erythema multiforme - pink rings with pale centres)
Chlamydophila pneumoniae
What scoring system is used to assess the severity/mortality of pneumonia?
CURB-65
Confusion
Urea >7 mmol/L
Respiratory rate >30
Blood pressure <90 systolic or <60 diastolic
> 65 years
Score of 0/1 - consider treatment at home
Score of 2 or more - consider hospital admission
Score of 3 or more - consider intensive care
Most common type/cause of pneumonia in HIV patients
Pneumocystis pneumonia caused by the fungus pneumocystis jirovecii.
Cystic fibrosis
RF
PATHOLOGY
SYMPTOMS
INVESTIGATIONS
TREATMENTS
An autosomal recessive condition affecting the mucus glands.
RF- family history of CF, Caucasians
PATHOLOGY
Genetic mutation of the CFTR (Cystic fibrosis transmembrane conductance regulator) gene on chromosome 7. (most common is delta F508 (region) mutation)
Causes an abnormality of the chloride channel lining the lungs, intestines, pancreatic duct, sweat glands and reproductive organs.
Key consequences:
- Thick pancreatic and biliary secretions causing blockage of the ducts –> results in a lack of digestive enzymes e.g. pancreatic lipase in the digestive tract
- Thick airway secretions that reduce airway clearance, resulting in bacterial colonisation and susceptibility to airway infections. (Also ciliary dysfunction)
SYMPTOMS
- Respiratory –> Thick sticky sputum production, chronic cough, recurrent respiratory tract infections,
- Neonates –> Meconium ileus (not passing stool within first 24 hours of bring born, possible vomiting) - due to meconium being thick and sticky, getting stuck and obstructing the bowel
- GI –> Steatorrhoea (lack of lipase enzyme), bowel obstruction, abdominal pain/bloating (malnutrition)
- Others –> atrophy of vas deferens (and so infertility), salty sweat, failure to thrive
(Coarse crackles)
INVESTIGATIONS
GS - Sweat test (measures amount of chloride in the sweat- more chloride than usual) >6ommol/L
Faecal elastase test - decreased due to pancreatic insufficiency
Genetic test for CFTR gene- delta F508 mutation
- Screened for at birth with the newborn bloodspot test (New borns might have high immunoreactive trypsinogen)
TREATMENT
No cure
Conservative –> Chest physiotherapy (clears mucus), exercise (improves resp function), no smoking
Drugs –> Mucolytic drugs (N acetyl cysteine), CREON tablets (+ ADEK fat soluble vitamins for patients with pancreatic insufficiency), bronchodilator (salbutamol)
P.aeruginosa - Ciprofloxacin
S.aureus - Flucloxacillin